Gregory Downey

Dr. Downey is a professor of medicine, pediatrics, and immunology and genomic medicine at National Jewish Health where he also serves as executive vice president of Academic Affairs, and provost. He is also professor of medicine and immunology and microbiology and associate dean of Health Affairs at the University of Colorado in Denver.

2022 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Downey has served on the Board of Directors of the Lovelace Respiratory Institute and as a consultant for Angion in the development of novel anti-fibrotic compounds. No payments have been received from Angion. He previously served as a consultant for Biomotiv in the development of novel anti-inflammatory compounds. He served as a consultant for Altimmune for antiviral therapies. Dr. Downey served as a consultant for Translate Bio for ARDS treatment.